EnsoData is partnering with Blackstone Medical Services (BMS) to offer improved accessibility to diagnosis and treatment for millions of patients currently living with undiagnosed sleep apnea, the company announced recently.

“As sleep medicine evolves, the role of accessible technology has never been more critical,” EnsoData CEO Dr. Justin Mortara, Ph.D., said in a statement. “EnsoSleep PPG provides BMS with an avenue to reach more patients, no matter their location or ability to visit traditional sleep labs.”

According to a release, BMS will leverage EnsoData’s EnsoSleep PPG home sleep testing solution to equip primary care physicians with a method to reach patients suffering from sleep disorders.

BMS is a Medicare-approved, JCAHO-accredited and nationally recognized IDTF for home sleep testing.